| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |